Skip to content

Three Quick Facts: Indivior, Lookers and Stanley Gibbons


Three things you need to know in the financial markets this morning from investment writer, Tony Cross.


There’s a change been announced at the top for the specialist pharmaceuticals company Indivior LON:INDV this morning, with the company’s former Chief Finance and Operations Officer stepping up to take the helm. There’s no further detail and the outgoing CEO appears to be leaving on good terms, but the company has struggled with widening losses and the threat posed to the company by a US Department of Justice investigation into its best-selling opioid addiction treatment. Having been spun out of Reckitt Benckiser in 2014, shares traded around the £5 mark in 2018 before collapsing to just over 30p. On Friday, the closing price was 78.8p.


There’s an update from Lookers LON:LOOK this morning, who are still to file full year accounts and as such are set to see their shares suspended later in the week. Accounting irregularities have resulted in an in depth internal investigation and some scale can now be attributed to these, but the necessary audit process will push the company past the filing deadline. Non-cash adjustments of £19m are seen as being necessary and the company perhaps delivers some confidence by noting that 2019 will remain profitable on an underlying basis.

Stanley Gibbons

There’s a trading update out from stamp dealers Stanley Gibbons LON:SGI this morning, which offers some insight over its customers’ behaviour during the COVID-19 lockdown. During the five weeks to April 29th, sales were down 45% year-on-year, compared with an 11% decline over the eight weeks to June 21st. The company acknowledges that revenue generation in the sector is volatile anyway and expresses caution over the outlook but notes there’s sufficient headroom for the next 4-5 months without drawing further on the remaining £2m debt facility. Over the last eight weeks, online sales rose 100% year on year and the company’s flagship store on The Strand reopens today following redevelopment works which have been underway since the start of the year.

Sign up for three quick facts and more with our Free Daily Digest newsletter, every weekday morning.

Looking for great investing ideas? Sign up to our free newsletter.

Join us on WhatsApp

This article does not constitute investment advice. Make sure you do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

CME Group
FP Markets
Back To Top